TGF-β also activates SMAD2/3 and cooperates with IL-21 activity to promote naïve CD4+ T cell generation of Th17 cells, contributing to NASH-associated liver inflammation and HCC (11, 12). This evidence concerns the gene TGFB1 and hepatocellular carcinoma.